IRVINE, Calif., May 18, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced its 2008 Annual Report to stockholders has been made available on its newly redesigned website. The new site offers visitors enhanced content and a more user-friendly, online experience.
In addition to the already content-rich format of the previous site, patients, physicians and investors will find new, valuable information and resources, including a focus on product information and patient education. Features of the redesigned site include enhanced navigation tools and upgraded "key word" search functions. These improvements will allow visitors to move more easily around the site and quickly access the information they need.
"The updated website is designed to be an educational experience, providing a wealth of information for customers and patients alike," said Lloyd Malchow, SenoRx President and Chief Executive Officer. "We will continue to add and expand information as it becomes available, and view the website as a 'living instrument' constantly being improved and enhanced to meet the information needs of all our constituencies."
Patients are able to access detailed information on diagnosis and treatment options, while physicians will find an extensive array of pertinent information, including information on professional events, detailed product information and reimbursement guidelines. Physicians are invited to add a link on their own websites to the SenoRx site to assist their patients in accessing pertinent information. In addition, the Clinical Library section of the website has been redesigned to enhance access to an expanding library of clinical research and findings on SenoRx products. We have also added an area for our growing list of distribution partners, complete with global map and an area to add additional distributor-specific information.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3605